10Y UST4.55%-0.44%30Y MTG6.55%+0.92%SOFR3.59%-0.83%VNQ$99.48-0.54%XLRE$45.23-0.42%FED FUNDS3.63%
Real Estate Trail
Institutional Press Wire
PR Newswire · New York · Capital

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of AN2 Therapeutics, Inc. (NASDAQ: ANTX)

Via PR Newswire · July 20, 2026
Compiled by Real Estate Trail Editorial · July 20, 2026

Why this matters

Commercial real estate continues to digest a multi-year reset in cost of capital. Transaction velocity is below the 2019-2021 trend but improving, cap rates have stabilized across most stabilized property types, and the bid-ask gap has narrowed materially in the past two quarters. Sponsors with permanent capital and operating platforms have an advantage in the current execution environment. New York continues to bifurcate sharply: trophy office leasing at record rents, commodity Class B in conversion discussions or court-supervised processes. Rent-stabilized multifamily remains supply-constrained and tightly held. The next twelve months will continue to reward underwriting discipline and operational sophistication over balance-sheet aggression.

Editorial analysis · AI-assisted

Excerpt from PR Newswire:
NEW YORK, July 20, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating AN2 Therapeutics, Inc. (NASDAQ: ANTX) on behalf of the company's shareholders. The investigation seeks to determine wh…
Read the full article at PR Newswire

External link. Real Estate Trail does not republish source content.

Related coverageNew York · Capital